Cinapsys

Cinapsys is a South San Francisco-based biotechnology company focused on developing novel therapeutics for neurological and psychiatric disorders by targeting synaptic biology. The company was co-founded by Nobel laureate Dr. Thomas Südhof and Dr. Marius Wernig, leveraging their pioneering research into synaptic transmission and cellular reprogramming. Cinapsys aims to address the root causes of brain diseases by identifying and modulating the molecular mechanisms that govern synaptic connectivity and function. Their approach involves a proprietary platform designed to discover small molecules and other modalities that can restore synaptic health in conditions like Alzheimer's disease and schizophrenia. The company is currently in the pre-clinical stage and is backed by leading venture capital firms in the life sciences sector.